Literature DB >> 25856128

Mantle cell lymphoma: the changing landscape.

Andre Goy1.   

Abstract

Entities:  

Year:  2013        PMID： 25856128

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

1.  Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.

Authors:  Yuqin Song; Keshu Zhou; Dehui Zou; Jianfeng Zhou; Jianda Hu; Haiyan Yang; Huilai Zhang; Jie Ji; Wei Xu; Jie Jin; Fangfang Lv; Ru Feng; Sujun Gao; Haiyi Guo; Lei Zhou; Jane Huang; William Novotny; Pil Kim; Yiling Yu; Binghao Wu; Jun Zhu
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.